Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vext Science (TSE:VEXT)
CNQX:VEXT
Holding TSE:VEXT?
Track your performance easily
VEXT Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.18 - C$0.42
Previous CloseC$0.24
Volume20.50K
Average Volume (3M)58.22K
Market Cap
C$50.04M
Enterprise ValueC$49.79M
Total Cash (Recent Filing)$8.72M
Total Debt (Recent Filing)$8.54M
Price to Earnings (P/E)171.4
Beta0.95
Next Earnings
Aug 21, 2024EPS Estimate
-C$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding245,450,566
10 Day Avg. Volume67,153
30 Day Avg. Volume58,220
Standard Deviation0.19
R-Squared0.16
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.54
Price to Sales (P/S)6.13
Price to Cash Flow (P/CF)15.50
P/FCF Ratio30.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.43
Enterprise Value/Gross Profit3.64
Enterprise Value/Ebitda2.68
Forecast
1Y Price Target
C$0.57Price Target Upside138.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Vext Science News
PremiumCompany Announcements
Vext Science to Release Q3 2024 Financial Results
PremiumCompany Announcements
Vext Science Strikes Investor Relations Deal With PartnerCap
PremiumCompany Announcements
Vext Science Foresees Growth with Ohio’s Cannabis Program
PremiumCompany Announcements
Vext Science to Unveil Q2 2024 Financials
PremiumCompany Announcements
Vext Science Gears Up for Ohio Cannabis Sales
PremiumCompany Announcements
Vext Science Poised for Adult-Use Cannabis Market in Ohio
PremiumCompany Announcements
Vext Science Poised for Growth with Solid Q1 Results
PremiumCompany Announcements
Vext Science to Unveil Q1 2024 FinancialsBulls Say, Bears Say
Bulls Say
Debt ReductionVext reduced its net debt by ~$8M in Q423 by raising equity capital and swapping its convertible debentures for shares.
Financial PerformanceVext reported Q124 results that beat estimates, reflecting cost management and improved cash margins.
Market OpportunityOhio’s medical market generated ~$500M of cannabis sales, and adult-use sales could cause the Ohio cannabis market to surpass $2B within a couple of years.
Bears Say
Cost ManagementOngoing under-absorption of costs has eroded Vext’s liquidity buffer, creating a potential $10M cashflow gap by year-end 2024.
Profit MarginsMargins and adj. EBITDA retreated as investments into its assets for future growth had yet to begin fully contributing to revenues.
Sales PerformanceArizona sales were much softer than expected, which management attributed to a weaker consumer amid the high interest rate and inflationary environment.
---
Options Prices
Currently, No data available
---
Ownership Overview
60.94% Insiders
0.00% Mutual Funds
0.39% Other Institutional Investors
38.67% Public Companies and
Individual Investors
VEXT FAQ
What was Vext Science’s price range in the past 12 months?
Vext Science lowest stock price was C$0.18 and its highest was C$0.42 in the past 12 months.
What is Vext Science’s market cap?
Currently, no data Available
When is Vext Science’s upcoming earnings report date?
Vext Science’s upcoming earnings report date is Aug 21, 2024 which is 79 days ago.
How were Vext Science’s earnings last quarter?
Currently, no data Available
Is Vext Science overvalued?
According to Wall Street analysts Vext Science’s price is currently Undervalued.
Does Vext Science pay dividends?
Vext Science does not currently pay dividends.
What is Vext Science’s EPS estimate?
Vext Science’s EPS estimate is -C$0.01.
How many shares outstanding does Vext Science have?
Vext Science has 141,209,120 shares outstanding.
What happened to Vext Science’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vext Science?
Currently, no hedge funds are holding shares in TSE:VEXT
---
Vext Science Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$0.57 (138.94% Upside)
C$0.57 (138.94% Upside)
Insider Transactions
Bought Shares
Worth $55.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.58%
12-Months-Change
Fundamentals
Return on Equity
-2.50%
Trailing 12-Months
Asset Growth
19.47%
Trailing 12-Months
Company Description
Vext Science
Vext Science Inc. through its subsidiaries operates as agricultural technology, services, and property management company in Canada. It utilizes an integrated business model to oversee and execute all aspects of cultivation, extraction, manufacturing of THC products, CBD products, Vapen kitchens, Flower products, and accessories. The company provides management, advisory, cultivation, and dispensary services to not-for-profit entities in the medical marijuana field.
---
VEXT Earnings Call
Q1 2024
0:00 / 0:00
---
VEXT Stock 12 Month Forecast
Average Price Target
C$0.57
▲(138.94% Upside)
Technical Analysis
Vext Science
―
Cresco Labs
―
Centogene NV
―
Curaleaf Holdings
―
Green Thumb Industries
―
Best Analysts Covering VEXT
1 Year
1 Year Success Rate
4/15 ratings generated profit
1 Year Average Return
-25.69%
reiterated a buy rating 5 months ago
Copying Andrew Semple's trades and holding each position for 1 Year would result in 26.67% of your transactions generating a profit, with an average return of -25.69% per trade.
---